 |
 |
 |
 |
 |
 |
ECI Biotech announces bronze level sponsorship of WPI Venture Forum
DATELINE: WORCESTER, MA — March 31, 2009 — ECI Biotech of Worcester, MA is pleased to announce its Bronze level
sponsorship of the WPI Venture Forum. ECI Biotech is a premier developer and manufacturer of innovative, patented ExpressDetect® Diagnostics products for rapid infection detection.
The WPI Venture Forum is a 501 (c)(3) program of the Collaborative for Entrepreneurship & Innovation in the Department of Management at WPI that is directed by a volunteer Executive Board of leaders of regional businesses and service organizations, some of whom are WPI alumni. The WPI Venture Forum serves entrepreneurs who are seeking to begin their own technology-based businesses as well as service providers, sponsors, and investors (seeking pre-startup and early stage technology opportunities) by providing knowledge through programs and a venue in which to network.
WPI Venture Forum activities include Monthly Programs and a concurrent
Newsletter, free Networking Events, a weekly Radio Program, an annual
Breakfast event, and an annual Business Plan Contest. Membership consists of entrepreneurs, investors, service providers, researchers, inventors, and WPI faculty, alumni, and students. Dr. Mitchell Sanders, the CEO and Founder of ECI Biotech, currently serves as the Chairman
of the Executive Board of the WPI Venture Forum.
Innovations and Applications
ECI Biotech’s executive offices and research facilities are located at 85 Prescott Street, in Worcester, Massachusetts. ECI Biotech is a leading edge protein sensor company with strong intellectual property of particular value for diagnostic sensors and therapeutics. Founded in 1998, its technologies relate to the detection of microbial pathogens and stabilizing active proteins to protect against infection.
ECI Biotech has four areas of core competence: molecular biology, genomics, protein expression, and assay development. ECI’s target markets for its products include: feminine care, wound care, oral care, and hospital infection control.
ECI Biotech's product pipeline includes a diagnostic sensor for urinary
tract infections, as well as advanced wound care systems that provide early warning of emergent infections and promote healing. ECI presently has corporate partnerships with medical device industry leaders, and has 18 patents pending and three patents issued.
For additional information please contact Dr. Mitchell Sanders at
sanders@ecibiotech.com, call 508-752-2209, or visit www.ecibiotech.com
.